SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?


To: Harold Engstrom who wrote (615)2/18/1998 5:49:00 PM
From: Purebull  Respond to of 1686
 
NEW YORK, Feb 18 (Reuters) - Prudential Securities analyst Caroline Copinthorne said she downgraded her rating on Biogen Inc to hold from buy due to the stock's price. said made no change to view of company's fundamental outlook or to earnings estimates. maintained $48 12-month price target. shares were off 3/4 at 43.